Promotional submissions are produced by commercial teams and reviewed outside eCTD — then, at the last moment, they must be published and transmitted like any other sequence. The most common failure is the right document under the wrong heading.
Key takeaways
- Since June 2021, Form 2253 promotional submissions must be in eCTD format.
- Every 2253 submission has three required parts, and they live in three different places in Module 1.
- Module 1.15 is structured: audience, then materials, each with its own material ID and issue date.
- Design for advisory requests and accelerated approval from the start — they share the same skeleton.
Promotional material submissions are the odd one out in regulatory operations. The content is produced by commercial teams, reviewed under a medical-legal-regulatory process that has nothing to do with eCTD, and then has to be published and transmitted as a properly structured electronic submission.
Since June 2021 that last step has been mandatory in eCTD format, under FDA’s final guidance Providing Regulatory Submissions in Electronic and Non-Electronic Format — Promotional Labeling and Advertising Materials for Human Prescription Drugs (June 2019). What follows is a practical walk through where things go.
Three components, three places
A postmarketing promotional submission under Form FDA 2253 has three required components: the completed Form FDA 2253, the current product labeling for the promoted product, and a clean copy of the promotional material itself. Everything else is optional or situational.
The list looks trivial. The difficulty is that the three items live in three different parts of Module 1, none of them adjacent, and two of them in headings most publishing teams rarely touch outside promotional work.
Teams coming from an NDA or BLA background instinctively look for a single folder holding “the promotional submission”. There isn’t one.
Module 1.15 has structure of its own
The promotional material heading is qualified by intended audience — professional or consumer — and beneath it, 1.15.2 holds the materials for a 2253 submission. Each material gets its own node with its own attributes, including a material ID and an issue date, with the clean file underneath.
Two consequences catch teams out. The material ID is submission metadata, not a file-naming convention: it belongs in the eCTD attributes and should match the identifier the commercial team uses on the piece. And one submission can carry many materials, each with its own node, ID and issue date — it is closer to a container of identified artifacts than to a single document package.
A promotional submission is a container of independently identified materials, not a single document package.
Other submission types share the skeleton
Form 2253 postmarketing submissions are the highest-volume case, but Module 1.15 also handles requests for advisory comments (including launch materials), accelerated approval submissions under 21 CFR 314.550 where materials are reviewed before dissemination, and responses to OPDP correspondence under 1.15.1. Teams that script 2253 publishing as a one-off usually rewrite it the first time an advisory request or an accelerated-approval product appears.
Details that are easy to get wrong
| Detail | What to do |
|---|---|
| Regional DTD version | Use the US regional DTD v3.3 or later; older backbones fail validation. |
| Draft versus current labeling | A 2253 carries the current approved labeling. Draft labeling is for accelerated approval and advisory submissions only. |
| Cross-referencing labeling | If current labeling is already on file, cross-reference it under 1.14.6 instead of re-sending — provided the earlier submission is findable and current. |
| Audience | Professional and consumer materials sit under different qualifications of 1.15. A consumer piece under the professional heading is a structural error. |
A publishing problem, not a marketing problem
Promotional material feels as if it belongs to commercial. But the moment a piece is approved, the obligation becomes a regulatory publishing obligation with a hard deadline: the material must reach FDA at the time of initial dissemination. Teams that encode the structure once — rather than rebuild it per piece — spend far less time on promotional submissions and reject far fewer.
Primary sources. Verify against the current FDA guidance on promotional submissions in electronic format, the OPDP eCTD resource page, and the Comprehensive Table of Headings for eCTD Module 1. This article is general information, not regulatory advice.
Promotional submissions, structured once
DnXT Publisher builds 1.15 materials with their audience, material type, ID and issue date, and validates them against FDA’s criteria.
